Glenn Dubin Steps Down From Mount Sinai Board
Glenn Dubin has stepped down from the board of Mount Sinai hospital, according to sources close to the institution. Mount Sinai has given a different account of the timing. The hospital said the Dubins' terms on its board of trustees ended in spring 2026 and that they did not seek re-election.
Dubin is a founder of Highbridge Capital Management, an investment firm that runs hedge funds, which are pooled investment funds typically open to wealthy investors and institutions. In January 2020, Reuters reported that he had retired from the hedge fund industry after 40 years to focus on private investments. The same month, the Financial Times reported that he had decided to sever ties with the near-$1bn fund he founded.
His ties to Mount Sinai are longer and more visible. Dubin first joined the hospital's boards of trustees in 2004. He and his wife, Eva Andersson-Dubin, MD, founded the Dubin Breast Center of The Tisch Cancer Institute at Mount Sinai. A journal for the hospital's Crystal Party, an annual event, listed both of them as trustees in May 2025. The journal for the 41st edition of the event, held in May 2026, did not list either of them on the trustees list as of 31 March 2026.
Andersson-Dubin stepped down earlier in 2026 from the board of Mount Sinai's Icahn School of Medicine, the hospital's medical school.
The hospital has reportedly formed a committee earlier in 2026 to review its longstanding ties to Jeffrey Epstein, according to the Guardian.
The Dubins' departures come against a wider set of questions about Epstein. Congressman Thomas Massie, a member of the U.S. House of Representatives, alleged on the House floor that Glenn Dubin was one of 14 Epstein co-conspirators who should be investigated and possibly prosecuted.
